Rising Tide Foundation for Clinical Cancer Research – Clinical Research Grants
Supports global, patient-centered Phase I–III interventional clinical trials in cancer to advance treatment options and improve quality of life.
Funder: Brown University
Due Dates: June 22, 2026 (Letter of Intent)
Funding Amounts: Amount not specified; details available in full RFA; awards typically support interventional clinical trials (Phase I–III) in cancer.
Summary: Supports innovative, patient-centered Phase I–III clinical cancer trials globally to improve treatment options and quality of life.
Key Information: Only interventional Phase I–III trials; basic research, Phase IV, and observational studies are not eligible.
Description
The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) Clinical Research Grants program funds innovative, patient-centered interventional clinical trials (Phase I–III) in cancer. The goal is to improve treatment options and quality of life for cancer patients through studies focused on detection, treatment, or implementation. Grants are open to academic and not-for-profit institutions worldwide, provided effective grant oversight is feasible. The program does not support basic research, Phase IV trials, or observational studies. Full details on priorities, eligibility, and application requirements are outlined in the official RFA.
